Search Results 2761-2770 of 16412 for Chronic Lymphocytic Leukemia
This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment. Mayo ...
The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...
Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC. Adv Radiat Oncol. 2019 Apr-Jun; 4 (2):422-428 Epub 2019 Jan 24. View ...
... diagnosis of an IEM or are a first degree relative of an individual with an IEM and to improve the diagnosis of IEMs by establishing and/or refining disease ...
Clinical diagnosis of possible, laboratory-supported probable, probable or ... diagnosis of a similar neurodegenerative disorder. ≥ 18 years of age ...
New diagnosis of HER2+ breast cancer, ... Current ACE inhibitor or ABR therapy for hypertension in the presence of diabetes and/or for chronic kidney disease/ ...
Undergoing treatment for acute or chronic hepatitis C. Have any clinically significant medical or surgical condition that, in the Investigator's opinion ...
Although CAR-T cell therapy shows promise for people with recurrent blood cancer, the side effects are generally severe. Study participants will report ...
History of severe COPD or severe restrictive lung disease (e.g. FEV1 <50%); Participation in any other study involving investigational drugs or devices; Severe ...
About this study. Hypertension is the major risk factor for cardiovascular and cerebrovascular diseases worldwide. The escalating prevalence of inadequate ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.